Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. Publications & data
Filter by
  • Filter by
  • Infectious disease
    • Vaccine preventable diseases (2940)
    • Respiratory diseases (1858)
    • Influenza (1158)
    • Mosquito-borne diseases (1062)
    • Food- and waterborne diseases (913)
    • Zoonosis (833)
    • Measles (693)
    • West Nile virus infection (652)
    • Sexually transmitted infections (522)
    • Tuberculosis (496)
    • Flu (432)
    • Seasonal influenza (432)
    • Influenza in humans, seasonal (432)
    • Rubella (387)
    • German measles (387)
    • Viral haemorrhagic fever (361)
    • Poliomyelitis (327)
    • HIV infection (298)
    • Human immunodeficiency virus infection (298)
    • Acquired immunodeficiency syndrome (AIDS) (298)
    • Dengue (287)
    • Viral hepatitis (287)
    • Ebola haemorrhagic fever (277)
    • Vector organisms (261)
    • Zoonotic influenza (239)
    • Avian influenza virus (228)
    • Middle East respiratory syndrome coronavirus (223)
    • Chikungunya virus disease (214)
    • Influenza A (H1N1) (214)
    • Healthcare-associated infections (203)
    • Coronavirus (201)
    • Influenza A (H1N1)2009 (197)
    • Salmonellosis (194)
    • COVID-19 (186)
    • SARS-CoV-2 (186)
    • Hepatitis A (168)
    • Nosocomial infections (129)
    • Tick-borne diseases (118)
    • Zika virus disease (113)
    • Cholera (111)
    • Legionnaires’ disease (107)
    • Mosquitoes (107)
    • Yellow fever (100)
    • Hepatitis B (99)
    • Ebola outbreak - North Kivu, Ituri, DRC (96)
    • Malaria (92)
    • Escherichia coli infection (90)
    • Campylobacteriosis (88)
    • Listeriosis (85)
    • Sandfly (84)
    • Phlebotomus (84)
    • Hepatitis C (83)
    • Influenza in humans, avian origin (81)
    • Influenza A (H9N2) (80)
    • Gonorrhoea (77)
    • Avian influenza in humans (72)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (65)
    • Multidrug-resistant tuberculosis (65)
    • Verotoxigenic Escherichia coli infection (65)
    • Shiga toxin producing Escherichia coli (STEC) infection (65)
    • Hepatitis (62)
    • Ticks (61)
    • Syphilis (56)
    • Pneumococcal disease (56)
    • Invasive pneumococcal disease (56)
    • Streptococcus pneumoniae (56)
    • S. pneumoniae (56)
    • Chlamydia infection (53)
    • Whooping cough (52)
    • Invasive meningococcal disease (52)
    • Tick-borne encephalitis (TBE) (52)
    • Meningococcal disease (52)
    • Pertussis (52)
    • Vector-borne disease (49)
    • Influenza in humans, pandemic (47)
    • Botulism (44)
    • Diphtheria (44)
    • Hospital-acquired infections (43)
    • Influenza in humans, swine origin (41)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (40)
    • Shigellosis (39)
    • Anthrax (38)
    • Cryptosporidiosis (38)
    • Yersiniosis (36)
    • Crimean-Congo haemorrhagic fever (34)
    • Influenza A(H7N9) virus (34)
    • Plague (33)
    • Mumps (33)
    • Emerging disease (33)
    • Zika virus disease - Outbreak in the Americas (33)
    • Haemophilus infection (32)
    • Haemophilus influenzae type b (HiB) infection (32)
    • Community acquired infections (32)
    • Invasive Haemophilus influenzae disease (32)
    • Trichinellosis (32)
    • Leptospirosis (32)
    • Giardiasis (31)
    • Ebola outbreak - West Africa (31)
    • Brucellosis (30)
    • Vibrio (29)
    • Ebola outbreak - Equateur province, DRC (29)
    • Rift Valley fever (28)
    • Enterovirus (28)
    • Coxsackievirus (28)
    • Influenza A(H5N1) virus (27)
    • Cutaneous warts (27)
    • Hydatidosis (27)
    • Human papillomavirus infection (27)
    • Echinococcosis (27)
    • Rabies (26)
    • Q fever (24)
    • Norovirus infection (24)
    • Tularaemia (23)
    • Tetanus (22)
    • Marburg haemorrhagic fever (22)
    • Clostridium difficile infection (22)
    • Marburg virus diseases (22)
    • Paratyphoid fever (21)
    • Typhoid and paratyphoid fever (21)
    • Enteric fever (21)
    • Foodborne diseases (21)
    • Hepatitis E (19)
    • Surgical site infections (19)
    • Carbapenem-resistant Enterobactericae (19)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (18)
    • Nephropathia epidemica (18)
    • Hantavirus infection (18)
    • Varicella (17)
    • Lassa fever (17)
    • Chickenpox (17)
    • Borreliosis (16)
    • Toxoplasmosis, congenital (16)
    • Lyme disease (16)
    • Severe acute respiratory syndrome (SARS) (16)
    • Lymphogranuloma venereum (15)
    • Infections in long-term care facilities (15)
    • Swine-origin influenza (15)
    • Latent tuberculosis infection (15)
    • Travel related infections (14)
    • Gastrointestinal disease (14)
    • Syphilis, congenital (13)
    • Congenital syphilis (13)
    • Extensively drug-resistant tuberculosis (XDR-TB) (13)
    • Drug-resistant tuberculosis (13)
    • Smallpox (13)
    • Variant Creutzfeldt-Jakob disease (vCJD) (12)
    • Creutzfeldt-Jakob disease (12)
    • Influenza A(H5N8) virus (12)
    • Congenital rubella (11)
    • Infections in intensive care units (11)
    • Klebsiella pneumoniae (11)
    • Haemorrhagic fever (10)
    • Snail fever (9)
    • Bilharziasis (9)
    • Schistosomiasis (9)
    • Extrapulmonary tuberculosis (9)
    • Mycobacterium chimaera (8)
    • Infections in acute care hospitals (8)
    • Influenza A(H5N2) virus (8)
    • Biting midge (8)
    • Sandfly-borne diseases (7)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (7)
    • Guillain-Barré syndrome (7)
    • Influenza A(H5N6) (7)
    • Monkeypox (6)
    • Disease vector (6)
    • Louse-borne diseases (6)
    • Leishmaniasis (6)
    • Rotavirus infection (6)
    • Waterborne diseases (5)
    • Schmallenberg virus (4)
    • Acinetobacter (4)
    • Japanese encephalitis virus (3)
    • Tick-borne relapsing fever (3)
    • Febris recurrens (2)
    • Candida auris (2)
    • Rickettsiosis (2)
    • Arenavirus (2)
    • Louse borne relapsing fever (2)
    • Sindbis fever (1)
    • Babesiosis (1)
    • Erythema infectiosum (1)
    • Hand, foot and mouth disease (1)
    • Ventilator-associated pneumonia (1)
    • Trench fever (1)
    • Louse-borne typhus (1)
    • Piroplasmosis (1)
    • Fifth disease (1)
    • Quintan fever (1)
    • Epidemic louse-borne typhus (1)
    • Anaplasmosis (1)
  • Public health area
    • Surveillance (3120)
    • Public health threat (1099)
    • Outbreak (1099)
    • Threats and outbreaks (1099)
    • Prevention and control (430)
    • Disease prevention (420)
    • Prophylaxis (420)
    • Active immunisation (392)
    • Vaccination (392)
    • Immunisation (392)
    • Scientific advice (381)
    • Antimicrobial resistance (371)
    • Antibiotic resistance (371)
    • Microbiology (357)
    • Epidemiology (347)
    • Epidemic (188)
    • Determinant (175)
    • Preparedness (157)
    • Health communication (152)
    • Public health response (100)
    • Control campaign (100)
    • Molecular typing (89)
    • Vaccination coverage (85)
    • Laboratories (82)
    • Antimicrobial consumption (82)
    • Migrant health (77)
    • Laboratory based surveillance (77)
    • Diagnostic test (68)
    • Infectious diseases on aircrafts (67)
    • Travellers' health (67)
    • Preventive measure (63)
    • Training (63)
    • Transmission of disease (58)
    • Climate change (53)
    • Mass gathering (42)
    • Vaccine safety (38)
    • Laboratory quality (36)
    • Pandemic preparedness (35)
    • Epidemic intelligence (34)
    • National reference laboratory (33)
    • Reference laboratory (33)
    • Vaccine effectiveness (32)
    • Case management (27)
    • Health inequality (22)
    • Vaccine efficacy (20)
    • Burden of communicable diseases (20)
    • Hospital infection control (19)
    • Vaccine hesitancy (19)
    • Laboratory capacity (17)
    • Public health education (16)
    • Antiviral (16)
    • Whole genome sequencing (16)
    • HIV testing (16)
    • Hand hygiene (14)
    • Pregnant women (14)
    • Crisis communication (12)
    • Injecting drug users (IDUs) (12)
    • Intravenous drug users (12)
    • Antimicrobial stewardship (12)
    • People who inject drugs (PWID) (12)
    • Risk communication (12)
    • Country cooperation (12)
    • High-risk groups (11)
    • Biosafety (10)
    • Personal protective equipment (10)
    • Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) (9)
    • Multidrug resistance (8)
    • Childhood vaccination (8)
    • Community engagement (8)
    • Laboratory guideline (7)
    • Health literacy (6)
    • Blood safety (6)
    • Hospital hygiene (4)
    • Point prevalence survey (4)
    • Substance of human origin (4)
    • Social marketing (3)
    • Bioterrorism (3)
    • Outbreak communication (2)
    • Health advocacy (1)
    • Intensive care unit (ICU) (1)
  • Publication series
    • Communicable Disease Threats Report (CDTR) (458)
    • Annual Epidemiological Report on Communicable Diseases in Europe (282)
    • Influenza Virus Characterisation (93)
    • Monitoring Implementation of the Dublin Declaration (49)
    • Bi-annual measles and rubella monitoring report (36)
    • Monthly measles and rubella monitoring report (36)
    • Annual Report of the Director (25)
    • Tuberculosis surveillance in Europe (24)
    • The European Union One Health Zoonoses Report (14)
    • Avian influenza overview (14)
    • HIV/AIDS Surveillance in Europe (13)
    • Antimicrobial resistance surveillance in Europe (11)
    • Gonococcal antimicrobial susceptibility surveillance in Europe (10)
    • EU summary report on AMR in zoonotic bacteria (9)
    • Legionnaires’ disease in Europe (7)
    • Core competencies (6)
    • Sexually transmitted infections in Europe (5)
    • Migrant health series (5)
    • Surveillance of antimicrobial consumption in Europe (4)
    • Surveillance of invasive bacterial diseases (4)
    • Summary of key publications (3)
    • Annual threat report (2)
    • Multi-annual programme (2)
  • Country
    • Europe (3893)
    • Africa (283)
    • Asia (233)
    • Americas (147)
    • North America (62)
    • European Neighbourhood Policy countries (43)
    • EU Candidate Countries (18)
    • Pacific regions (16)
    • Indian Ocean (14)
    • Nothern Africa (10)
    • Oceania (10)
    • ENP (6)
    • EU Potential Candidates (1)
  • Media type
    • Publication (3630)
    • Data (2463)
    • Surveillance report (1208)
    • Map (1134)
    • Peer-reviewed publication (909)
    • Table (394)
    • Technical report (369)
    • Risk assessment (346)
    • Country profile (295)
    • Graph (263)
    • Corporate publication (174)
    • Infographic (150)
    • Technical guidance (142)
    • Tool (122)
    • Meeting report (91)
    • External quality assessment (77)
    • Factsheet (71)
    • Video (60)
    • Presentation (53)
    • Mission report (41)
    • Public health guidance (28)
    • Literature review (21)
    • Leaflet (21)
    • Poster (15)
    • Expert opinion (13)
    • Communication toolkit (10)
    • Systematic review (9)
    • Toolkit (7)
    • Case definition (5)
    • News (2)
    • Epidemiological update (2)
  • All (6093)
  • Publication (3630)
  • Data (2463)
  • Page 1 de 609 // 6083 Résultats trouvés
    • Sort by:

Publication

Communicable disease threats report, 17-23 January 2021, week 3

Publication - 22 Jan 2021

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 January 2021 and includes updates on Legionnaires' disease, COVID-19, dengue, influenza, avian influenza A(H5N6), avian influenza A(H9N2), poliomyelitis and chikungunya.

Communicable disease threats report, 17-23 January 2021, week 3 - EN - [PDF-3.63 MB]
  • Avian influenza virus
  • Chikungunya virus disease
  • China
  • Coronavirus
  • COVID-19
  • Dengue
  • EU/EEA
  • Influenza
  • Influenza A (H9N2)
  • Influenza A(H5N6)
  • Legionnaires’ disease
  • Poliomyelitis
  • Portugal
  • Public health threat

Data

Data on country response measures to COVID-19

Data - 21 Jan 2021

This downloadable data file contains information on non-pharmaceutical interventions (or response measures) that countries in the EU/EEA have reported to date.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on testing for COVID-19 by week and country

Data - 21 Jan 2021

The downloadable data file contains information about testing volume for COVID-19 by week and country. Each row contains the corresponding data for a country and a week. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

  • Coronavirus
  • COVID-19
  • Public health threat

Data

Data on hospital and ICU admission rates and current occupancy for COVID-19

Data - 21 Jan 2021

The downloadable data files contain information about hospitalisation and Intensive Care Unit (ICU) admission rates and current occupancy for COVID-19 by date and country. Each row contains the corresponding data for a certain date (day or week) and per country. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on 14-day notification rate of new COVID-19 cases and deaths

Data - 21 Jan 2021

These files contain data on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population and 14-day notification rate of reported deaths per million population by week and country, in EU/EEA and the UK. Each row contains the corresponding data for a given indicator, week and country. The files are updated weekly. You may use the data in accordance to ECDC’s copyright policy.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on the daily subnational 14-day notification rate of new COVID-19 cases

Data - 21 Jan 2021

The downloadable data file contains information on the 14-day notification rate of new cases per 100 000 inhabitants for COVID-19 by day and subnational region. Each row contains the corresponding data for a certain day and per subnational region. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

The source is either TESSy COVID-19, subnational daily data, or an official Github source, or an official website.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on the weekly subnational 14-day notification rate of new COVID-19 cases

Data - 21 Jan 2021

The downloadable data file contains information on the 14-day notification rate of new cases per 100 000 inhabitants for COVID-19 by day and subnational region. Each row contains the corresponding data for a certain epidemiological week and per subnational region. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

  • Coronavirus
  • COVID-19
  • Public health threat
  • Surveillance

Data

Data on the 14-day age-specific notification rate of new COVID-19 cases

Data - 21 Jan 2021

The downloadable data file contains information on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population by age group, week and country. Each row contains the corresponding data for a certain week and country. The file is updated weekly. You may use the data in line with ECDC’s copyright policy.

Data

Data for the maps in support of the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in the EU/EEA

Data - 21 Jan 2021

The downloadable data file contains the data on which the maps requested in the Council Recommendation on a coordinated approach to the restriction of free movement in response to the COVID-19 pandemic in EU/EEA are based. They are published every Thursday.

  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • United Kingdom

Publication

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update

Risk assessment - 21 Jan 2021

This risk assessment presents the latest available information on the recent emergence of three variants of concern, VOC 202012/01 identified in the United Kingdom (UK), 501Y.V2 identified in South Africa, and P.1 identified in Brazil and Japan.

Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update - EN - [PDF-1.46 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Surveillance

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Dernier »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us